Age
Item
age more than 18 years
boolean
C0001779 (UMLS CUI [1])
Paroxysmal atrial fibrillation Disease length | Episode Symptomatic Quantity
Item
paroxysmal af for at least 6 months with at least 3 symptomatic episodes (using patient history) during the previous 6 months
boolean
C0235480 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0332189 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Patients Appropriate Ablation Atrial Fibrillation | ATRIAL FIBRILLATION SYMPTOMATIC | Atrial Fibrillation Unresponsive to Treatment | Intolerance to Anti-Arrhythmia Agents Class Quantity
Item
patients must be felt to be candidates for af ablation based on af that is symptomatic and refractory or intolerant to at least one class 1 or 3 antiarrhythmic agent.
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C0547070 (UMLS CUI [1,3])
C0004238 (UMLS CUI [1,4])
C0741283 (UMLS CUI [2])
C0004238 (UMLS CUI [3,1])
C0205269 (UMLS CUI [3,2])
C1744706 (UMLS CUI [4,1])
C0003195 (UMLS CUI [4,2])
C0456387 (UMLS CUI [4,3])
C1265611 (UMLS CUI [4,4])
Atrial Fibrillation Episode Quantity 12 lead ECG | Other Coding | Atrial Fibrillation Episode Quantity Holter Electrocardiography
Item
documentation of at least one episode of af on 12 lead ecg, ttm or holter monitor within 12 months of randomization in the trial
boolean
C0004238 (UMLS CUI [1,1])
C0332189 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0430456 (UMLS CUI [1,4])
C3846158 (UMLS CUI [2])
C0004238 (UMLS CUI [3,1])
C0332189 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0013801 (UMLS CUI [3,4])
Anticoagulation Therapy | Warfarin | International Normalized Ratio | Subcutaneous heparin Fractionated | Transesophageal Echocardiography Excludes Thrombus of left atrium
Item
patients must be on continuous anticoagulation with warfarin (inr 2-3) or fractionated subcutaneous heparin for >4 weeks prior to the ablation or they have undergone a recent (less than 48 hours before planned ablation) transoesophageal echocardiogram to exclude left atrial thrombus.
boolean
C0003281 (UMLS CUI [1])
C0043031 (UMLS CUI [2])
C0525032 (UMLS CUI [3])
C0353681 (UMLS CUI [4,1])
C1979893 (UMLS CUI [4,2])
C0206054 (UMLS CUI [5,1])
C0332196 (UMLS CUI [5,2])
C3532827 (UMLS CUI [5,3])
Informed Consent
Item
patients must provide written informed consent to participate in the clinical trial.
boolean
C0021430 (UMLS CUI [1])
Medical contraindication Oral anticoagulants
Item
contraindications to oral anticoagulants
boolean
C1301624 (UMLS CUI [1,1])
C0354604 (UMLS CUI [1,2])
Ablation Atrial Fibrillation In the past | Surgical Maze Procedure In the past
Item
history of any previous ablation or surgical maze for af
boolean
C0547070 (UMLS CUI [1,1])
C0004238 (UMLS CUI [1,2])
C1444637 (UMLS CUI [1,3])
C3272262 (UMLS CUI [2,1])
C1444637 (UMLS CUI [2,2])
Intracardiac thrombus
Item
intracardiac thrombus
boolean
C0876998 (UMLS CUI [1])
Atrial Fibrillation Due to Cause Reversible
Item
af due to reversible cause
boolean
C0004238 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0015127 (UMLS CUI [1,3])
C0205343 (UMLS CUI [1,4])
Left atrium Size | Diseases of mitral valve | MITRAL STENOSIS MODERATE | Mitral Valve Stenosis Severe | Mitral regurgitation Moderate | Mitral regurgitation Severe
Item
patients with left atrial size > 55mm or significant mitral valve disease (moderate or severe mitral stenosis or regurgitation)
boolean
C0225860 (UMLS CUI [1,1])
C0456389 (UMLS CUI [1,2])
C0026265 (UMLS CUI [2])
C0746601 (UMLS CUI [3])
C0026269 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0026266 (UMLS CUI [5,1])
C0205081 (UMLS CUI [5,2])
C0026266 (UMLS CUI [6,1])
C0205082 (UMLS CUI [6,2])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Asthma | Bronchial Spasm | Adverse reactions Adenosine
Item
asthma, history of bronchospasm or known adverse reaction to adenosine
boolean
C0004096 (UMLS CUI [1])
C0006266 (UMLS CUI [2])
C0559546 (UMLS CUI [3,1])
C0001443 (UMLS CUI [3,2])